Coverbild der Sendung Compounded Semaglutide — Is It Safe?

Compounded Semaglutide — Is It Safe?

Podcast von Inception Point AI

Englisch

Gesundheit & Persönliche Entwicklung

Begrenztes Angebot

2 Monate für 1 €

Dann 4,99 € / MonatJederzeit kündbar.

  • 20 Stunden Hörbücher / Monat
  • Podcasts nur bei Podimo
  • Alle kostenlosen Podcasts
Loslegen

Mehr Compounded Semaglutide — Is It Safe?

Dr. Ben Synth exposes the hidden dangers of compounded semaglutide through FDA data, quality control failures, and hundreds of adverse events. Discover why the cheaper alternative to brand-name weight-loss drugs may carry serious risks—from dosing errors to contaminated ingredients—and what patients need to know now. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.

Alle Folgen

4 Folgen

Episode Compounded Semaglutide — Is It Safe? - Separate fact from fiction with Dr. Ben Synth Cover

Compounded Semaglutide — Is It Safe? - Separate fact from fiction with Dr. Ben Synth

Dr. Ben Synth investigated the booming compounded semaglutide market and uncovered hundreds of adverse event reports, alarming impurity levels, and dosing errors hidden in an unregulated gray zone. This series exposes the supply chain risks, mystery ingredients, and legal loopholes behind those cheaper weight-loss injections. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. Apr. 2026 - 39 s
Episode Compounded Semaglutide — Is It Safe? - The Shortage Loophole: A Billion-Dollar Wild West Cover

Compounded Semaglutide — Is It Safe? - The Shortage Loophole: A Billion-Dollar Wild West

Ben Synth examines how the FDA's drug shortage exemption allowed compounding pharmacies to produce cheaper semaglutide alternatives during the Ozempic and Wegovy shortage, creating a billion-dollar gray market with serious safety risks, dosing errors, and regulatory gaps that left millions of patients navigating uncertain ground. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. Apr. 2026 - 26 min
Episode Compounded Semaglutide — Is It Safe? - What's Actually in That Vial Cover

Compounded Semaglutide — Is It Safe? - What's Actually in That Vial

Ben Synth examines disturbing findings from Novo Nordisk testing: some compounded semaglutide samples contained 33% impurities, including formaldehyde, trace metals, and banned substances like BPC-157. We discuss supply chain risks, unvetted foreign suppliers, non-pharmaceutical grade ingredients, sterility failures, and fraudulent labeling that distinguish compounded versions from FDA-approved Ozempic and Wegovy. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. Apr. 2026 - 18 min
Episode Compounded Semaglutide — Is It Safe? - 605 Adverse Events and Counting Cover

Compounded Semaglutide — Is It Safe? - 605 Adverse Events and Counting

Ben Synth examines the dangers of compounded semaglutide, a cheaper alternative to FDA-approved weight loss drugs like Ozempic and Wegovy. The episode covers over 600 adverse events reported to the FDA, including severe overdoses, hospitalizations, and life-threatening complications. Through detailed analysis of regulatory data and clinical reports, Ben explores dosing errors, quality control failures, and the risks patients face. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

7. Apr. 2026 - 20 min
Melde dich an, um zu hören
Super gut, sehr abwechslungsreich Podimo kann man nur weiterempfehlen
Super gut, sehr abwechslungsreich Podimo kann man nur weiterempfehlen
Ich liebe Podcasts, Hörbücher u. -spiele, Dokus usw. Hier habe ich genügend Auswahl. Macht 👍 weiter so

Wähle dein Abonnement

Am beliebtesten

Begrenztes Angebot

Premium

20 Stunden Hörbücher

  • Podcasts nur bei Podimo

  • Keine Werbung in Podimo Podcasts

  • Jederzeit kündbar

2 Monate für 1 €
Dann 4,99 € / Monat

Loslegen

Premium Plus

100 Stunden Hörbücher

  • Podcasts nur bei Podimo

  • Keine Werbung in Podimo Podcasts

  • Jederzeit kündbar

30 Tage kostenlos testen
Dann 13,99 € / monat

Kostenlos testen

Nur bei Podimo

Beliebte Hörbücher

Häufig gestellte Fragen

Weitere Fragen und Antworten
Loslegen

2 Monate für 1 €. Dann 4,99 € / Monat. Jederzeit kündbar.